Use of deoxynyboquinone in the preparation of anti-inflammatory or antioxidant drugs

CN112451523BActive Publication Date: 2026-08-28UNIV OF MACAU +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202011461094.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-12-11
Publication Date
2026-08-28
Estimated Expiration
2040-12-11

AI Technical Summary

Technical Problem

[0003]目前，Deoxynyboquinone的研究主要集中于抗癌活性方面，其它方面的作用还有待进一步研究

Benefits of technology

[0031]本申请首次提出Deoxynyboquinone在制备抗炎药物或抗氧化药物中的应用，其能够通过多重生物学机制有效抑制炎症反应，可作为炎症反应的临床治疗中较为有效且毒副作用较小的候选药物，并且，其具有良好的抗氧化作用，可作为抗氧化反应临床治疗中较为有效且毒副作用较小的候选药物。此外，本申请还提出了活性成分包括Deoxynyboquinone的药物，其具有较高的抗炎及抗氧化应激活性，具备良好的市场潜力和价值。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112451523B_ABST
    Figure CN112451523B_ABST
Patent Text Reader

Abstract

The application discloses application of Deoxynyboquinone in preparation of anti-inflammatory drugs or antioxidant drugs and belongs to the technical field of biological medicines. Deoxynyboquinone can effectively inhibit inflammatory reactions through multiple biological mechanisms and can be used for preparation of anti-inflammatory drugs. In addition, Deoxynyboquinone also has an antioxidant effect and can be used for preparation of antioxidant drugs. The active ingredient of the drug containing Deoxynyboquinone has high anti-inflammatory and antioxidant stress activities and has good market potential and value.
Need to check novelty before this filing date? Find Prior Art

Claims

1. The use of deoxynyboquinone in the preparation of drugs for treating acute inflammation.

2. The application according to claim 1, wherein, The drug also includes a pharmaceutically acceptable carrier.

3. The application according to claim 1, wherein, The drug is available in oral or injectable form.

4. The application according to claim 3, wherein, The oral dosage form is tablet, granule, solution, powder or capsule.

5. The application according to claim 3, wherein, The injection dosage form is either an injection solution or a powder injection.

Citation Information

Patent Citations

  • Combination of cancer therapeutics for treatment of cancer and hyperproliferative diseases

    WO2019113345A1